Investigating how visual and touch senses work together as a new marker for Alzheimer's disease

Visual-somatosensory integration as a novel marker of Alzheimer's disease

NIH-funded research State University New York Stony Brook · NIH-11263347

This study is looking at how well the brain combines what we see and feel to find new ways to spot Alzheimer's disease early, and it's for older adults, whether they have early signs of the disease or not, to help improve their safety and well-being.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-11263347 on NIH RePORTER

What this research studies

This research focuses on identifying new, non-invasive markers for Alzheimer's disease by examining how well the brain integrates visual and touch information. It aims to understand how sensory, cognitive, and motor functions interact and change as Alzheimer's disease progresses. By studying older adults with and without preclinical Alzheimer's, the research seeks to uncover the underlying brain networks involved in these processes. The findings could lead to new interventions aimed at preventing falls and other non-cognitive issues in individuals with cognitive impairments.

Who could benefit from this research

Good fit: Ideal candidates for this research are community-dwelling older adults, both with and without preclinical Alzheimer's disease.

Not a fit: Patients with advanced Alzheimer's disease or those with severe cognitive impairments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a new way to detect Alzheimer's disease earlier and help develop strategies to prevent related complications.

How similar studies have performed: Previous research has shown promise in using sensory integration as a marker for cognitive decline, suggesting this approach may yield valuable insights.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.